Role of mitomycin C in the development of late bowel toxicity following chemoradiation for locally advanced carcinoma of the cervix

International Journal of Radiation Oncology Biology Physics

Volumn 38, Issue 5, 1997, Pages 979-987

  Rakovitch, Eileen ^a   Fyles, Anthony W ^a,c   Pintilie, Melania ^b   Leung, Philip M K ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Cervix cancer; Complications; Mitomycin C; Radiotherapy

Indexed keywords

FLUOROURACIL; MITOMYCIN C;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; DRUG EFFECT; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; INTESTINAL DISEASES; MIDDLE AGED; MITOMYCIN; NEOPLASM STAGING; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 0030804916     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00121-1     Document Type: Article

References (31)

1. Brundage, M. D.; Pater, J. L.; Zee, B. Assessing the reliability of two toxicity scales: Implications for interpreting toxicity data. J. Natl. Cancer Inst. 85:1138-1148; 1993.
2. Christie, D. R. H.; Bull, C. A.; Gebske, V.; Langlands, A. O. Concurrent 5-fluorouracil, mitomycin C and irradiation in locally advanced cervix cancer. Radiother. Oncol. 36:181-189; 1995.
3. Coia, L.; Won, M.; Lanciano, R.; Marcial, V. A.; Martz, K.; Hanks, G. The patterns of care outcome study for cancer of the uterine cervix. Results of the Second National Practise Survey. Cancer 66:2451-2456; 1990.
4. Crook, J. M.; Esche, B. A.; Chaplain, G.; Isturiz, J.; Sentenac, I.; Horiot, J. Dose-volume analysis and the prevention of radiation sequelae in cervical cancer. Radiother. Oncol. 8:321-332; 1987.
5. Cummings, B. J.; Keane, T. J.; O'Sullivan, B.; Wong, C. S.; Catton, C. N. Epidermoid anal cancer: Treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int. J. Radiat. Oncol. Biol. Phys. 21:1115-1125; 1991.
6. DeVita, V. T.; Hellman, S.; Rosenberg, S. A. Cancer. Principles and practice of oncology, 4th ed. Philadelphia: J. B. Lippincott; 1993.
7. Dobrowsky, W.; Dobrowsky, E.; Rauth, A. M. Mode of interaction of 5-fluorouracil, radiation, and mitomycin C: In vitro studies. Int. J. Radiat. Oncol. Biol. Phys. 22:875-880; 1992.
8. Eifel, P. J.; Levenback, C.; Wharton, J. T.; Oswald, M. J. Time course and incidence of late complications in patients treated with radiation therapy for FIGO Stage IB carcinoma of the uterine cervix. Int. J. Radiat. Oncol. Biol. Phys. 32:1289-1300; 1995.
9. Evans, L.; Kersh, C. R.; Constable, W. C.; Taylor, P. T. Concomitant 5-fluorouracil, mitomycin-C, and radiotherapy for advanced gynecologic malignancies: Int. J. Radiat. Oncol. Biol. Phys. 15:901-906; 1988.
10. Flam, M.; John, M.; Pajak, T.; Petrelli, N.; Myerson, R.; Doggett, S.; Quivey, J.; Rotman, M.; Kerman, H.; Coia, L.; Murray, K. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a Phase III randomized intergroup study. J. Clin. Oncol. 14:2527-2539; 1996.
11. Haie-Meder, C.; Kramar, A.; Lambin, P.; Lancar, R.; Scalliet, P.; Bouzy, J.; Gerbaulet, A. Analysis of complications in a prospective randomized trial comparing two brachytherapy low dose rates in cervical carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 29:953-960; 1994.
12. International Committee on Radiation Units and Measurements. ICRU Report 38. Bethesda, MD; 1985.
13. John, M.; Flam, M.; Sikic, B.; Rotman, M.; Cooper, J.; Malec, M.; Hannigan, J.; Phillips, T. Preliminary results of concurrent radiotherapy and chemotherapy in advanced cervical carcinoma: A Phase I-II prospective intergroup NCOG-RTOG study. Gynecol. Oncol. 37:1-5; 1990.
14. Keane, T. J.; Harwood, A. R.; Elhakim, T.; Rider, W. D.; Cummings, B. J.; Ginsberg, R. J.; Cooper, J. C. Radical radiation therapy with 5-fluorouracil infusion and mitomycin C for oesophageal squamous carcinoma. Radiother. Oncol. 4:205-210; 1985.
15. Kersh, C. R.; Constable, W. C.; Spaulding, C. A.; Hahn, S. S.; Andersen, W. A.; Taylor, P. T. A Phase I-II trial of multimodality management of bulky gynecologic malignancy. Combined chemoradiosensitization and radiotherapy. Cancer 66:30-34; 1990.
16. Khoury, G. G.; Bulman, A. S.; Joslin, C. A. F.; Rothwell, R. I. Concomitant pelvic irradiation, 5-fluorouracil and mitomycin C in the treatment of advanced cervical carcinoma. Br. J. Radiol. 64:252-260; 1991.
17. Lanciano, R. M.; Martz, D.; Montana, G. S.; Hanks, G. E. Influence of age, prior abdominal surgery, fraction size, and dose on complications after radiation therapy for squamous cell cancer of the uterine cervix. A Patterns of Care study. Cancer 69:2124-2130; 1992.
18. Ludgate, S. M.; Crandon, A. J.; Hudson, C. N.; Walker, Q.; Langlands, A. O. Synchronous 5-fluorouracil, mitomycin C and radiation therapy in the treatment of locally advanced carcinoma of the cervix. Int. J. Radiat. Oncol. Biol. Phys. 15:893-899; 1988.
19. Malviya, V. K.; Deppe, G.; Kim, Y.; Gove, N. Concurrent radiation therapy, cis-platinum, and mitomycin C in patients with poor prognosis cancer of the cervix: A pilot study. Am. J. Clin. Oncol. 12:434-437; 1989.
20. Malviya, V. K.; Han, I.; Deppe, G.; Malske, J. M.; Christensen, C. W.; Kim, Y.; Ahmad, K. High-dose-rate afterloading brachytherapy, external radiation therapy, and combination chemotherapy in poor-prognosis cancer of the cervix. Gynecol. Oncol. 42:233-238; 1991.
21. Montana, G. S.; Fowler, W. C. Carcinoma of the cervix: Analysis of bladder and rectal radiation dose and complications: Int. J. Radiat. Oncol. Biol. Phys. 16:95-100; 1989.
22. Nguyen, P. D.; John, B.; Munoz, A. K.; Yazigi, R.; Graham, M.; Franklin, P. Mitomycin-C/5-FU and radiation therapy for locally advanced uterine cervical cancer. Gynecol. Oncol. 43:220-225; 1991.
23. Orton, C. G.; Wolf-Rosenblum, S. Dose dependence of complication rates in cervix cancer radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 12:37-44; 1986.
24. Parker, S. L.; Tong, T.; Bolden, S.; Wingo, P. A. Cancer statistics. CA Cancer J. Clin. 46:5-27; 1996.
25. Perez, C. A.; Breaux, S.; Bedwinek, J. M.; Madoc-Jones, H.; Camel, H. M.; Purdy, J. A.; Walz, B. J. Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II. Analysis of complications. Cancer 54:235-246; 1984.
26. Perez, C. A.; Kuske, R. R.; Camel, H. M.; Galakatos, A. E.; Hederman, M. A.; Kao, M.; Walz, B. J. Analysis of pelvic tumor control and impact on survival in carcinoma of the uterine cervix treated with radiation therapy alone. Int. J. Radiat. Oncol. Biol. Phys. 14:613-621; 1988.
27. Rauth, A. M.; Marshall, R. S.; Kuehl, B. L. Cellular approaches to bioreductive drug mechanisms. Cancer Metastas. Rev. 12:153-164; 1993.
28. Stryker, J. A.; Bartholomew, M.; Velkley, D. E.; Cunningham, D. E.; Mortel, R.; Craycraft, G.; Shafer, J. Bladder and rectal complications following radiotherapy for cervix cancer. Gynecol. Oncol. 29:1-11; 1988.
29. Smitskamp-Wilms, E.; Ciaccone, G.; Pinedo, H. M.; van der Laan, BFAM; Peters, G. J. DT-diaphorase activity in normal and neoplastic human tissues: An indicator for sensitivity to bioreductive agents? Br. J. Cancer 72:917-921; 1995.
30. Thomas, G.; Dembo, A.; Fyles, A.; Gadalla, T.; Beale, F.; Bean, H.; Pringle, J.; Rawlings, G.; Bush, R.; Black, B. Concurrent chemoradiation in advanced cervical cancer. Gynecol. Oncol. 38:446-451; 1990.
31. Thomas, G.; Dembo, A.; Beale, F.; Bean, H.; Bush, R.; Herman, J.; Pringle, J.; Rawlings, G.; Sturgeon, J.; Fine, S.; Black, B. Concurrent radiation, mitomycin C, and 5-fluorouracil in poor prognosis carcinoma of the cervix: Preliminary results of a phase I-II study. Int. J. Radiat. Oncol. Biol. Phys. 10:1785-1790; 1984.